From: Massively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy
Case No.
Mutation primary tumour
Mutation metastasis
F1
11: p.V559G
n.a.
F2
Wt
F3
9: p.A502_Y503dup
F4
F5
11: p.V559D
F6
F7
F8
p.W557_V559delinsF
F9
p.V559A